查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1574766

糖尿病眼科疾病设备市场：按产品类型、最终用户、适应症、技术 - 全球预测 2025-2030

Diabetic Eye Disease Devices Market by Product Type (Diagnostic Devices, Treatment Devices), End User (Ambulatory Surgical Centers, Hospitals, Ophthalmic Clinics), Indication, Technology - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 192 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年糖尿病眼科疾病设备市场价值为173.8亿美元，预计2024年将达到189.2亿美元，复合年增长率为9.56%，预计到2030年将达到329.5亿美元。

糖尿病眼科疾病设备覆盖范围包括各种旨在诊断、监测和治疗糖尿病引起的眼部相关併发症的医疗设备和技术，包括糖尿病视网膜病变、糖尿病黄斑部水肿、白内障和医疗设备。这些设备对于预防糖尿病患者视力丧失和失明至关重要，并且已成为医疗保健系统的必需品。典型应用包括影像系统，例如光同调断层扫瞄、筛检工具、雷射治疗和人工水晶体。最终用途范围包括医院、专业眼科诊所和积极管理糖尿病患者眼睛健康的研究机构。全球糖尿病盛行率不断上升、人们对糖尿病併发症的认识不断提高，以及诊断影像和微创治疗解决方案的技术进步，对市场成长产生了重大影响。由于糖尿病人口的快速增长和未满足的医疗保健需求，亚太市场扩张的机会比比皆是。治疗方法包括投资远端医疗平台和人工智慧主导的诊断工具，以提高早期检测和治疗能力。然而，先进设备成本高、法规环境严格、农村地区的可及性有限等限制因素为市场拓展带来了挑战。持续的研究和开发对于探索个人化医疗方法、机器人辅助手术工具和增强的影像模式等创新至关重要，这些创新可能会彻底改变患者的治疗结果并扩大市场份额。市场是动态的，其特征是技术快速发展和主要参与者之间的竞争联盟。在新兴经济体，专注于开发具有成本效益的可携式设备和扩大分销网络的公司将取得长足进展。此外，与非营利组织和政府卫生计画建立合作伙伴关係可以潜在地提高可及性和市场渗透率。儘管整体前景看好，但必须谨慎应对糖尿病眼科疾病设备市场的挑战，以充分利用糖尿病眼科疾病整体管理的新兴机会。

主要市场统计
基准年[2023] 173.8亿美元
预测年份 [2024] 189.2亿美元
预测年份 [2030] 329.5亿美元
复合年增长率（%） 9.56%

市场动态：快速发展的糖尿病眼科疾病设备市场的关键市场洞察

供需的动态交互作用正在改变糖尿病眼科疾病设备市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，并了解消费行为及其对製造成本的影响，并更清楚地了解对采购趋势的影响。

  • 市场驱动因素
    • 在糖尿病眼科保健中更多地采用远端医疗和数位健康解决方案
    • 行业主要企业之间的合作以促进创新和市场拓展
    • 增加糖尿病视网膜病变治疗的研发投入
    • 透过扩大新兴市场的医疗基础设施来增加获得治疗的机会
  • 市场限制因素
    • 糖尿病眼科疾病设备的高资本成本和产品召回
  • 市场机会
    • 先进的人工智慧驱动平台，可准确诊断糖尿病眼科疾病
    • 为服务不足的糖尿病患者提供经济实惠的便携式筛检工具
    • 糖尿病视网膜病变非侵入性治疗仪的开发
  • 市场挑战
    • 缺乏熟练的专业人员和设备的技术限制

波特五力：驾驭糖尿病眼科疾病设备市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解糖尿病眼科疾病设备市场的外部影响

外部宏观环境因素在塑造糖尿病眼科疾病设备市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助企业预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解糖尿病眼科疾病设备市场的竞争格局

对糖尿病眼科疾病设备市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，以应对日益激烈的竞争。

FPNV 定位矩阵糖尿病眼科疾病设备市场供应商的绩效评估

FPNV 定位矩阵是评估糖尿病眼科疾病设备市场供应商的关键工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，以确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议描绘了糖尿病眼科疾病设备市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，对糖尿病眼科疾病设备市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 在糖尿病眼科保健中更多地采用远端医疗和数位健康解决方案
      • 产业主要企业之间的合作创新与拓展市场
      • 增加糖尿病视网膜病变治疗研发投资
      • 扩大新兴市场的医疗保健基础设施改善获得护理的机会
    • 抑制因素
      • 糖尿病眼科疾病设备的高资本成本和产品召回
    • 机会
      • 尖端人工智慧驱动平台，精准诊断糖尿病眼科疾病
      • 为服务不足的糖尿病患者提供负担得起的便携式筛检工具
      • 糖尿病视网膜病变非侵入性治疗设备的开发
    • 任务
      • 缺乏熟练的专业人员和设备的技术限制
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章糖尿病眼科疾病设备市场：依产品类型

  • 诊断设备
    • 萤光萤光造影
    • 眼底摄影机
    • 光学同调断层扫描(OCT) 扫描仪
  • 治疗设备
    • 人工水晶体(IOL)
    • 雷射系统
      • 光凝雷射
      • 光破坏雷射
    • 玻璃体切除装置

第七章糖尿病眼科疾病设备市场：依最终使用者分类

  • 门诊手术中心
  • 医院
  • 眼科诊所

第八章糖尿病眼科疾病设备市场（依适应症）

  • 糖尿病黄斑部水肿（DME）
    • 扩散二甲醚
    • 焦点测距仪
  • 糖尿病视网膜病变
    • 非增殖性糖尿病视网膜病变
    • 增殖性糖尿病视网膜病变

第九章糖尿病眼科疾病设备市场：依技术分类

  • 玻璃体内注射
  • 雷射治疗
  • 玻璃体切除手术

第十章美洲糖尿病眼科疾病设备市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章亚太糖尿病眼科疾病设备市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章欧洲、中东和非洲糖尿病眼科疾病设备市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议
Product Code: MRR-535C6291891B

The Diabetic Eye Disease Devices Market was valued at USD 17.38 billion in 2023, expected to reach USD 18.92 billion in 2024, and is projected to grow at a CAGR of 9.56%, to USD 32.95 billion by 2030.

The scope of diabetic eye disease devices encompasses a range of medical equipment and technologies designed to diagnose, monitor, and treat eye-related complications arising from diabetes, including diabetic retinopathy, diabetic macular edema, cataracts, and glaucoma. These devices are crucial in preventing vision impairment and blindness in diabetic patients, making them a necessity within the healthcare system. Primary applications include imaging systems like optical coherence tomography, screening tools, laser therapies, and intraocular lenses. The end-use scope covers hospitals, specialized eye clinics, and research institutes actively managing diabetic eye health. Market growth is significantly influenced by the rising prevalence of diabetes globally, increasing awareness about diabetic complications, and technological advancements in diagnostic imaging and minimally invasive treatment solutions. Opportunities abound in expanding markets in Asia-Pacific due to burgeoning diabetic populations and unmet healthcare needs. Recommendations include investing in telemedicine platforms and AI-driven diagnostic tools that can enhance early detection and treatment capabilities. However, limitations such as high costs of advanced devices, stringent regulatory environments, and limited accessibility in rural regions challenge market expansion. Continuous R&D is essential in exploring innovations like personalized medicine approaches, robotic-assisted surgical tools, and enhanced imaging modalities, which could revolutionize patient outcomes and expand market presence. The market is dynamic, characterized by rapid technological evolution and competitive collaborations among key players. Organizations focusing on developing cost-effective, portable devices and expanding distribution networks in emerging economies stand to make significant strides. Furthermore, fostering partnerships with non-profits and governmental health programs could bolster accessibility and market penetration. Overall, while promising, the diabetic eye disease devices market requires careful navigation of its challenges to fully capitalize on the burgeoning opportunities for holistic management of diabetic eye conditions.

KEY MARKET STATISTICS
Base Year [2023] USD 17.38 billion
Estimated Year [2024] USD 18.92 billion
Forecast Year [2030] USD 32.95 billion
CAGR (%) 9.56%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Diabetic Eye Disease Devices Market

The Diabetic Eye Disease Devices Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing adoption of telemedicine and digital health solutions for diabetic eye care
    • Collaborations between key industry players to innovate and expand market reach
    • Growing investments in research and development for diabetic retinopathy treatments
    • Expansion of healthcare infrastructure in emerging markets increasing access to care
  • Market Restraints
    • High capital costs and product recalls of diabetic eye disease devices
  • Market Opportunities
    • Cutting-edge AI-driven platforms for accurate diabetic eye disease diagnostics
    • Affordable and portable screening tools for underserved diabetic populations
    • Development of non-invasive therapeutic devices for diabetic retinopathy treatment
  • Market Challenges
    • Limited availability of skilled professionals and technical limitations with devices

Porter's Five Forces: A Strategic Tool for Navigating the Diabetic Eye Disease Devices Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Diabetic Eye Disease Devices Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Diabetic Eye Disease Devices Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Diabetic Eye Disease Devices Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Diabetic Eye Disease Devices Market

A detailed market share analysis in the Diabetic Eye Disease Devices Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Diabetic Eye Disease Devices Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Diabetic Eye Disease Devices Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Diabetic Eye Disease Devices Market

A strategic analysis of the Diabetic Eye Disease Devices Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Diabetic Eye Disease Devices Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Alcon Inc., Allergan plc, Bayer AG, BD (Becton, Dickinson and Company), Carl Zeiss AG, Clearside Biomedical, Inc., F. Hoffmann-La Roche Ltd, Genentech, Inc., GlaxoSmithKline plc, Iveric Bio, Inc., Novartis AG, Ocular Therapeutix, Inc., Optos plc, Pfizer Inc., Regeneron Pharmaceuticals, Inc., Sanofi S.A., Santen Pharmaceutical Co., Ltd., Topcon Corporation, and Vitreoretinal Technologies, Inc..

Market Segmentation & Coverage

This research report categorizes the Diabetic Eye Disease Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product Type, market is studied across Diagnostic Devices and Treatment Devices. The Diagnostic Devices is further studied across Fluorescein Angiography, Fundus Cameras, and Optical Coherence Tomography (OCT) Scanners. The Treatment Devices is further studied across Intraocular Lenses (IOLs), Laser Systems, and Vitrectomy Devices. The Laser Systems is further studied across Photocoagulation Lasers and Photodisruption Lasers.
  • Based on End User, market is studied across Ambulatory Surgical Centers, Hospitals, and Ophthalmic Clinics.
  • Based on Indication, market is studied across Diabetic Macular Edema (DME) and Diabetic Retinopathy. The Diabetic Macular Edema (DME) is further studied across Diffuse DME and Focal DME. The Diabetic Retinopathy is further studied across Non-Proliferative Diabetic Retinopathy and Proliferative Diabetic Retinopathy.
  • Based on Technology, market is studied across Intravitreal Injections, Laser Therapy, and Vitrectomy.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing adoption of telemedicine and digital health solutions for diabetic eye care
      • 5.1.1.2. Collaborations between key industry players to innovate and expand market reach
      • 5.1.1.3. Growing investments in research and development for diabetic retinopathy treatments
      • 5.1.1.4. Expansion of healthcare infrastructure in emerging markets increasing access to care
    • 5.1.2. Restraints
      • 5.1.2.1. High capital costs and product recalls of diabetic eye disease devices
    • 5.1.3. Opportunities
      • 5.1.3.1. Cutting-edge AI-driven platforms for accurate diabetic eye disease diagnostics
      • 5.1.3.2. Affordable and portable screening tools for underserved diabetic populations
      • 5.1.3.3. Development of non-invasive therapeutic devices for diabetic retinopathy treatment
    • 5.1.4. Challenges
      • 5.1.4.1. Limited availability of skilled professionals and technical limitations with devices
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Diabetic Eye Disease Devices Market, by Product Type

  • 6.1. Introduction
  • 6.2. Diagnostic Devices
    • 6.2.1. Fluorescein Angiography
    • 6.2.2. Fundus Cameras
    • 6.2.3. Optical Coherence Tomography (OCT) Scanners
  • 6.3. Treatment Devices
    • 6.3.1. Intraocular Lenses (IOLs)
    • 6.3.2. Laser Systems
      • 6.3.2.1. Photocoagulation Lasers
      • 6.3.2.2. Photodisruption Lasers
    • 6.3.3. Vitrectomy Devices

7. Diabetic Eye Disease Devices Market, by End User

  • 7.1. Introduction
  • 7.2. Ambulatory Surgical Centers
  • 7.3. Hospitals
  • 7.4. Ophthalmic Clinics

8. Diabetic Eye Disease Devices Market, by Indication

  • 8.1. Introduction
  • 8.2. Diabetic Macular Edema (DME)
    • 8.2.1. Diffuse DME
    • 8.2.2. Focal DME
  • 8.3. Diabetic Retinopathy
    • 8.3.1. Non-Proliferative Diabetic Retinopathy
    • 8.3.2. Proliferative Diabetic Retinopathy

9. Diabetic Eye Disease Devices Market, by Technology

  • 9.1. Introduction
  • 9.2. Intravitreal Injections
  • 9.3. Laser Therapy
  • 9.4. Vitrectomy

10. Americas Diabetic Eye Disease Devices Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Diabetic Eye Disease Devices Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Diabetic Eye Disease Devices Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Alcon Inc.
  • 3. Allergan plc
  • 4. Bayer AG
  • 5. BD (Becton, Dickinson and Company)
  • 6. Carl Zeiss AG
  • 7. Clearside Biomedical, Inc.
  • 8. F. Hoffmann-La Roche Ltd
  • 9. Genentech, Inc.
  • 10. GlaxoSmithKline plc
  • 11. Iveric Bio, Inc.
  • 12. Novartis AG
  • 13. Ocular Therapeutix, Inc.
  • 14. Optos plc
  • 15. Pfizer Inc.
  • 16. Regeneron Pharmaceuticals, Inc.
  • 17. Sanofi S.A.
  • 18. Santen Pharmaceutical Co., Ltd.
  • 19. Topcon Corporation
  • 20. Vitreoretinal Technologies, Inc.

LIST OF FIGURES

  • FIGURE 1. DIABETIC EYE DISEASE DEVICES MARKET RESEARCH PROCESS
  • FIGURE 2. DIABETIC EYE DISEASE DEVICES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. DIABETIC EYE DISEASE DEVICES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. DIABETIC EYE DISEASE DEVICES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. DIABETIC EYE DISEASE DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. DIABETIC EYE DISEASE DEVICES MARKET DYNAMICS
  • TABLE 7. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY FLUORESCEIN ANGIOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY FUNDUS CAMERAS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY OPTICAL COHERENCE TOMOGRAPHY (OCT) SCANNERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TREATMENT DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY INTRAOCULAR LENSES (IOLS), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY LASER SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY PHOTOCOAGULATION LASERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY PHOTODISRUPTION LASERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY LASER SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY VITRECTOMY DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TREATMENT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY OPHTHALMIC CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC MACULAR EDEMA (DME), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIFFUSE DME, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY FOCAL DME, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC MACULAR EDEMA (DME), 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC RETINOPATHY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY NON-PROLIFERATIVE DIABETIC RETINOPATHY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY PROLIFERATIVE DIABETIC RETINOPATHY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC RETINOPATHY, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY INTRAVITREAL INJECTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY LASER THERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY VITRECTOMY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 38. AMERICAS DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. AMERICAS DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2030 (USD MILLION)
  • TABLE 40. AMERICAS DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TREATMENT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 41. AMERICAS DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY LASER SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 42. AMERICAS DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 43. AMERICAS DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 44. AMERICAS DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC MACULAR EDEMA (DME), 2018-2030 (USD MILLION)
  • TABLE 45. AMERICAS DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC RETINOPATHY, 2018-2030 (USD MILLION)
  • TABLE 46. AMERICAS DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 47. AMERICAS DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 48. ARGENTINA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. ARGENTINA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2030 (USD MILLION)
  • TABLE 50. ARGENTINA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TREATMENT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 51. ARGENTINA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY LASER SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 52. ARGENTINA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 53. ARGENTINA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 54. ARGENTINA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC MACULAR EDEMA (DME), 2018-2030 (USD MILLION)
  • TABLE 55. ARGENTINA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC RETINOPATHY, 2018-2030 (USD MILLION)
  • TABLE 56. ARGENTINA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 57. BRAZIL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. BRAZIL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2030 (USD MILLION)
  • TABLE 59. BRAZIL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TREATMENT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 60. BRAZIL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY LASER SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 61. BRAZIL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 62. BRAZIL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 63. BRAZIL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC MACULAR EDEMA (DME), 2018-2030 (USD MILLION)
  • TABLE 64. BRAZIL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC RETINOPATHY, 2018-2030 (USD MILLION)
  • TABLE 65. BRAZIL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 66. CANADA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. CANADA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2030 (USD MILLION)
  • TABLE 68. CANADA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TREATMENT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 69. CANADA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY LASER SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 70. CANADA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 71. CANADA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 72. CANADA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC MACULAR EDEMA (DME), 2018-2030 (USD MILLION)
  • TABLE 73. CANADA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC RETINOPATHY, 2018-2030 (USD MILLION)
  • TABLE 74. CANADA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 75. MEXICO DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. MEXICO DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2030 (USD MILLION)
  • TABLE 77. MEXICO DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TREATMENT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 78. MEXICO DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY LASER SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 79. MEXICO DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 80. MEXICO DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 81. MEXICO DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC MACULAR EDEMA (DME), 2018-2030 (USD MILLION)
  • TABLE 82. MEXICO DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC RETINOPATHY, 2018-2030 (USD MILLION)
  • TABLE 83. MEXICO DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 84. UNITED STATES DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. UNITED STATES DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2030 (USD MILLION)
  • TABLE 86. UNITED STATES DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TREATMENT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 87. UNITED STATES DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY LASER SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 88. UNITED STATES DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 89. UNITED STATES DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 90. UNITED STATES DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC MACULAR EDEMA (DME), 2018-2030 (USD MILLION)
  • TABLE 91. UNITED STATES DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC RETINOPATHY, 2018-2030 (USD MILLION)
  • TABLE 92. UNITED STATES DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 93. UNITED STATES DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 94. ASIA-PACIFIC DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. ASIA-PACIFIC DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2030 (USD MILLION)
  • TABLE 96. ASIA-PACIFIC DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TREATMENT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 97. ASIA-PACIFIC DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY LASER SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 98. ASIA-PACIFIC DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 99. ASIA-PACIFIC DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 100. ASIA-PACIFIC DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC MACULAR EDEMA (DME), 2018-2030 (USD MILLION)
  • TABLE 101. ASIA-PACIFIC DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC RETINOPATHY, 2018-2030 (USD MILLION)
  • TABLE 102. ASIA-PACIFIC DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 103. ASIA-PACIFIC DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 104. AUSTRALIA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. AUSTRALIA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2030 (USD MILLION)
  • TABLE 106. AUSTRALIA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TREATMENT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 107. AUSTRALIA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY LASER SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 108. AUSTRALIA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 109. AUSTRALIA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 110. AUSTRALIA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC MACULAR EDEMA (DME), 2018-2030 (USD MILLION)
  • TABLE 111. AUSTRALIA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC RETINOPATHY, 2018-2030 (USD MILLION)
  • TABLE 112. AUSTRALIA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 113. CHINA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. CHINA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2030 (USD MILLION)
  • TABLE 115. CHINA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TREATMENT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 116. CHINA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY LASER SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 117. CHINA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 118. CHINA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 119. CHINA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC MACULAR EDEMA (DME), 2018-2030 (USD MILLION)
  • TABLE 120. CHINA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC RETINOPATHY, 2018-2030 (USD MILLION)
  • TABLE 121. CHINA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 122. INDIA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. INDIA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2030 (USD MILLION)
  • TABLE 124. INDIA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TREATMENT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 125. INDIA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY LASER SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 126. INDIA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 127. INDIA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 128. INDIA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC MACULAR EDEMA (DME), 2018-2030 (USD MILLION)
  • TABLE 129. INDIA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC RETINOPATHY, 2018-2030 (USD MILLION)
  • TABLE 130. INDIA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 131. INDONESIA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. INDONESIA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2030 (USD MILLION)
  • TABLE 133. INDONESIA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TREATMENT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 134. INDONESIA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY LASER SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 135. INDONESIA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 136. INDONESIA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 137. INDONESIA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC MACULAR EDEMA (DME), 2018-2030 (USD MILLION)
  • TABLE 138. INDONESIA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC RETINOPATHY, 2018-2030 (USD MILLION)
  • TABLE 139. INDONESIA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 140. JAPAN DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. JAPAN DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2030 (USD MILLION)
  • TABLE 142. JAPAN DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TREATMENT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 143. JAPAN DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY LASER SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 144. JAPAN DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 145. JAPAN DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 146. JAPAN DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC MACULAR EDEMA (DME), 2018-2030 (USD MILLION)
  • TABLE 147. JAPAN DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC RETINOPATHY, 2018-2030 (USD MILLION)
  • TABLE 148. JAPAN DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 149. MALAYSIA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 150. MALAYSIA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2030 (USD MILLION)
  • TABLE 151. MALAYSIA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TREATMENT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 152. MALAYSIA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY LASER SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 153. MALAYSIA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 154. MALAYSIA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 155. MALAYSIA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC MACULAR EDEMA (DME), 2018-2030 (USD MILLION)
  • TABLE 156. MALAYSIA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC RETINOPATHY, 2018-2030 (USD MILLION)
  • TABLE 157. MALAYSIA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 158. PHILIPPINES DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 159. PHILIPPINES DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2030 (USD MILLION)
  • TABLE 160. PHILIPPINES DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TREATMENT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 161. PHILIPPINES DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY LASER SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 162. PHILIPPINES DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 163. PHILIPPINES DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 164. PHILIPPINES DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC MACULAR EDEMA (DME), 2018-2030 (USD MILLION)
  • TABLE 165. PHILIPPINES DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC RETINOPATHY, 2018-2030 (USD MILLION)
  • TABLE 166. PHILIPPINES DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 167. SINGAPORE DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 168. SINGAPORE DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2030 (USD MILLION)
  • TABLE 169. SINGAPORE DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TREATMENT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 170. SINGAPORE DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY LASER SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 171. SINGAPORE DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 172. SINGAPORE DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 173. SINGAPORE DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC MACULAR EDEMA (DME), 2018-2030 (USD MILLION)
  • TABLE 174. SINGAPORE DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC RETINOPATHY, 2018-2030 (USD MILLION)
  • TABLE 175. SINGAPORE DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 176. SOUTH KOREA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 177. SOUTH KOREA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2030 (USD MILLION)
  • TABLE 178. SOUTH KOREA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TREATMENT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 179. SOUTH KOREA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY LASER SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 180. SOUTH KOREA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 181. SOUTH KOREA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 182. SOUTH KOREA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC MACULAR EDEMA (DME), 2018-2030 (USD MILLION)
  • TABLE 183. SOUTH KOREA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC RETINOPATHY, 2018-2030 (USD MILLION)
  • TABLE 184. SOUTH KOREA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 185. TAIWAN DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 186. TAIWAN DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2030 (USD MILLION)
  • TABLE 187. TAIWAN DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TREATMENT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 188. TAIWAN DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY LASER SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 189. TAIWAN DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 190. TAIWAN DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 191. TAIWAN DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC MACULAR EDEMA (DME), 2018-2030 (USD MILLION)
  • TABLE 192. TAIWAN DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC RETINOPATHY, 2018-2030 (USD MILLION)
  • TABLE 193. TAIWAN DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 194. THAILAND DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 195. THAILAND DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2030 (USD MILLION)
  • TABLE 196. THAILAND DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TREATMENT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 197. THAILAND DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY LASER SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 198. THAILAND DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 199. THAILAND DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 200. THAILAND DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC MACULAR EDEMA (DME), 2018-2030 (USD MILLION)
  • TABLE 201. THAILAND DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC RETINOPATHY, 2018-2030 (USD MILLION)
  • TABLE 202. THAILAND DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 203. VIETNAM DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 204. VIETNAM DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2030 (USD MILLION)
  • TABLE 205. VIETNAM DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TREATMENT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 206. VIETNAM DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY LASER SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 207. VIETNAM DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 208. VIETNAM DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 209. VIETNAM DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC MACULAR EDEMA (DME), 2018-2030 (USD MILLION)
  • TABLE 210. VIETNAM DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC RETINOPATHY, 2018-2030 (USD MILLION)
  • TABLE 211. VIETNAM DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 212. EUROPE, MIDDLE EAST & AFRICA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 213. EUROPE, MIDDLE EAST & AFRICA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2030 (USD MILLION)
  • TABLE 214. EUROPE, MIDDLE EAST & AFRICA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TREATMENT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 215. EUROPE, MIDDLE EAST & AFRICA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY LASER SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 216. EUROPE, MIDDLE EAST & AFRICA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 217. EUROPE, MIDDLE EAST & AFRICA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 218. EUROPE, MIDDLE EAST & AFRICA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC MACULAR EDEMA (DME), 2018-2030 (USD MILLION)
  • TABLE 219. EUROPE, MIDDLE EAST & AFRICA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC RETINOPATHY, 2018-2030 (USD MILLION)
  • TABLE 220. EUROPE, MIDDLE EAST & AFRICA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 221. EUROPE, MIDDLE EAST & AFRICA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 222. DENMARK DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 223. DENMARK DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2030 (USD MILLION)
  • TABLE 224. DENMARK DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TREATMENT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 225. DENMARK DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY LASER SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 226. DENMARK DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 227. DENMARK DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 228. DENMARK DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC MACULAR EDEMA (DME), 2018-2030 (USD MILLION)
  • TABLE 229. DENMARK DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC RETINOPATHY, 2018-2030 (USD MILLION)
  • TABLE 230. DENMARK DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 231. EGYPT DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 232. EGYPT DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2030 (USD MILLION)
  • TABLE 233. EGYPT DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TREATMENT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 234. EGYPT DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY LASER SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 235. EGYPT DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 236. EGYPT DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 237. EGYPT DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC MACULAR EDEMA (DME), 2018-2030 (USD MILLION)
  • TABLE 238. EGYPT DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC RETINOPATHY, 2018-2030 (USD MILLION)
  • TABLE 239. EGYPT DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 240. FINLAND DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 241. FINLAND DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2030 (USD MILLION)
  • TABLE 242. FINLAND DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TREATMENT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 243. FINLAND DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY LASER SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 244. FINLAND DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 245. FINLAND DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 246. FINLAND DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC MACULAR EDEMA (DME), 2018-2030 (USD MILLION)
  • TABLE 247. FINLAND DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC RETINOPATHY, 2018-2030 (USD MILLION)
  • TABLE 248. FINLAND DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 249. FRANCE DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 250. FRANCE DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2030 (USD MILLION)
  • TABLE 251. FRANCE DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TREATMENT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 252. FRANCE DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY LASER SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 253. FRANCE DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 254. FRANCE DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 255. FRANCE DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC MACULAR EDEMA (DME), 2018-2030 (USD MILLION)
  • TABLE 256. FRANCE DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC RETINOPATHY, 2018-2030 (USD MILLION)
  • TABLE 257. FRANCE DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 258. GERMANY DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 259. GERMANY DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2030 (USD MILLION)
  • TABLE 260. GERMANY DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TREATMENT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 261. GERMANY DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY LASER SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 262. GERMANY DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 263. GERMANY DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 264. GERMANY DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC MACULAR EDEMA (DME), 2018-2030 (USD MILLION)
  • TABLE 265. GERMANY DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC RETINOPATHY, 2018-2030 (USD MILLION)
  • TABLE 266. GERMANY DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 267. ISRAEL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 268. ISRAEL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2030 (USD MILLION)
  • TABLE 269. ISRAEL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TREATMENT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 270. ISRAEL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY LASER SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 271. ISRAEL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 272. ISRAEL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 273. ISRAEL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC MACULAR EDEMA (DME), 2018-2030 (USD MILLION)
  • TABLE 274. ISRAEL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC RETINOPATHY, 2018-2030 (USD MILLION)
  • TABLE 275. ISRAEL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 276. ITALY DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 277. ITALY DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2030 (USD MILLION)
  • TABLE 278. ITALY DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TREATMENT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 279. ITALY DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY LASER SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 280. ITALY DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 281. ITALY DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 282. ITALY DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC MACULAR EDEMA (DME), 2018-2030 (USD MILLION)
  • TABLE 283. ITALY DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC RETINOPATHY, 2018-2030 (USD MILLION)
  • TABLE 284. ITALY DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 285. NETHERLANDS DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 286. NETHERLANDS DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2030 (USD MILLION)
  • TABLE 287. NETHERLANDS DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TREATMENT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 288. NETHERLANDS DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY LASER SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 289. NETHERLANDS DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 290. NETHERLANDS DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 291. NETHERLANDS DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC MACULAR EDEMA (DME), 2018-2030 (USD MILLION)
  • TABLE 292. NETHERLANDS DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC RETINOPATHY, 2018-2030 (USD MILLION)
  • TABLE 293. NETHERLANDS DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 294. NIGERIA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 295. NIGERIA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2030 (USD MILLION)
  • TABLE 296. NIGERIA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TREATMENT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 297. NIGERIA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY LASER SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 298. NIGERIA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 299. NIGERIA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 300. NIGERIA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC MACULAR EDEMA (DME), 2018-2030 (USD MILLION)
  • TABLE 301. NIGERIA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC RETINOPATHY, 2018-2030 (USD MILLION)
  • TABLE 302. NIGERIA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 303. NORWAY DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 304. NORWAY DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2030 (USD MILLION)
  • TABLE 305. NORWAY DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TREATMENT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 306. NORWAY DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY LASER SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 307. NORWAY DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 308. NORWAY DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)

TABLE